News

KeyCorp Financial Review: Insights After 3Q Earnings Update

KeyCorp Financial Review: Insights After 3Q Earnings Update

KeyCorp's Earnings Performance Overview

Goldman Sachs recently reaffirmed its Buy rating on KeyCorp (NYSE: KEY) and set a stock price target at $19.00, following the release of the company’s third-quarter earnings report. In this report, KeyCorp disclosed an earnings per share (EPS) of ($0.47). When accounting for various one-time expenses such as a $918 million securities adjustment and a $6 million FDIC reversal, the core EPS is estimated to be $0.30. This figure slightly surpasses the consensus prediction of $0.28, attributed largely to lower operational costs.

Financial Highlights

KeyCorp’s core pre-provision net revenue (PPNR) stood out in the latest quarter, outperforming projections with a reported figure of $513 million compared to the anticipated $496 million. This positive performance was buoyed by a reduction in expenses as well as an improvement in net interest income (NII), which climbed to $952 million against the consensus estimate of $938 million. Despite some setbacks in core fee income, which totaled $649 million, slightly falling short of the $664 million expectation, the overall financial outlook remained robust.

Net Interest Margins and Loan Yields

The net interest margin (NIM) for KeyCorp was reported at 2.17%, marginally below the expected 2.20%. On the deposits front, the average deposits grew by 2.5% to reach $147.77 billion, exceeding forecasts by 1.9%. The demand deposit account (DDA) deposits experienced a modest quarter-over-quarter increase of 0.9%, resulting in a higher-than-expected deposit mix of 20.2% as opposed to the forecast of 19.1%.

Loan and Securities Insights

Regarding loan and securities yields, KeyCorp experienced a rise in loan yields by 7 basis points quarter-over-quarter, reaching 5.73%, which aligned with expectations. Securities yields also saw a rise, going up by 45 basis points to 2.87%, although this fell short of the anticipated 3.07% due to adjustments in the securities portfolio. The interest-bearing deposit costs rose by 11 basis points quarter-over-quarter to 2.96%, which was higher than the expected 2.88%.

Credit Losses and Loan Quality

A key metric of credit health, the provision for credit losses, came in lower than anticipated at $95 million, compared to the $104 million consensus. Nonetheless, net charge-offs were higher than expected at approximately 0.58 basis points against an anticipated 38 basis points. Despite this, the total criticized loans showed a 2% decrease while nonperforming loans (NPLs) rose by 2.5%, now sitting at 0.69%.

Capital Position and Future Guidance

KeyCorp's tangible book value per share (TBVPS) reflected a healthy increase of 15.8%, now at $11.72. The common equity Tier 1 (CET1) capital grew by 30 basis points to 10.8%, while adjusted CET1 capital experienced a significant jump of approximately 90 basis points quarter-over-quarter to around 8.6%.

As for future expectations, KeyCorp updated its full-year 2024 guidance, indicating a potential decrease in average loans while anticipating higher fees and expenses. The company reiterated its net interest income forecast while adjusting net charge-off expectations to the higher end of the previously estimated range.

Market Reactions and Analyst Perspectives

Analysts such as those at Barclays noted that KeyCorp’s EPS has exceeded expectations, maintaining an Equalweight rating with a $16 price target. On the other hand, Baird downgraded their view from Outperform to Neutral, reducing the price target to $17, citing a significant surge in the stock’s value.

Investment Adjustments

Recently, KeyCorp sold about $7 billion worth of low-yielding investment securities, which is projected to result in an after-tax loss of about $700 million for the third quarter of 2024. Despite adverse effects from this transaction, the company has lifted its 2024 fee income projections.

Future Financial Projections

Analysts from firms like Piper Sandler and Citi expressed optimism regarding KeyCorp’s future. Citi recently raised its EPS forecast for 2025 to $1.55, while Piper Sandler upheld an Overweight rating on the stock. Additionally, Jefferies has raised its price target for KeyCorp shares to $19.00, indicating sustained confidence in the bank's financial outlook.

Frequently Asked Questions

What is KeyCorp's current EPS?

KeyCorp's current EPS stands at ($0.47), although adjusted for one-time expenses, the core EPS is estimated at $0.30.

What are the primary challenges KeyCorp faces?

The main challenges include lower core fees and higher-than-expected net charge-offs, although PPNR has exceeded forecasts.

How has KeyCorp's tangible book value changed?

KeyCorp's tangible book value per share has increased by 15.8% to $11.72.

What ratings are analysts giving KeyCorp?

Analysts have mixed views, with Barclays maintaining an Equalweight rating and Baird downgrading to Neutral.

What is the outlook for KeyCorp's 2024 guidance?

KeyCorp projected a decline in average loans, with adjustments made to both net charge-off expectations and fee income guidance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

New CMO Joins ARTHEx: Boosting Innovative RNA Focus

Updated Category News Views 26

ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...

Continue Reading
Direct Connection Unleashes Powerful HEMI V8 Engine Programs

Updated Category News Views 75

HEMI V8 Legacy Reinvention at SEMA 2026 If you're the sort who gets their hands greasy restoring or revamping classic muscle, well, Direct Connection just made your life a whole lot easier. Stellantis' performance arm pulled the wraps off not just one, but six new HEMI V8 crate engine packages at the 2026 SEMA Show. Now, that's how you turn heads in Vegas. A New...

Continue Reading
Vietnam Pushes Tech Boundaries with VGC v1.0 Chip

Updated Category News Views 98

How often do you hear about a country stepping confidently into the tech realm with its own set of silicon-built security? This is exactly what's happening with Vietnam's ambitious leap with the VGC v1.0 chip, rolled out by the nation's Government Cipher Committee and Viettel Group. Hitting a level of speed that blows past the sluggish pace of software-only methods, this...

Continue Reading
Metacon Q3 Report Unveiled Amid Green Hydrogen Buzz

Updated Category News Views 114

Peeling Back Metacon's Q3 2026 Figures Alright, let's sink our teeth into the meat and potatoes of Metacon's latest report. The interim report for Q3 2026 hit the newsstands, but it's what's lurking behind the numbers that tells the real story. With all the green energy buzz, Metacon's report is a mixed bag, reflecting their uphill journey in hydrogen pursuits and...

Continue Reading
AbsenceSoft's AI Leave Planner Tackles HR Headaches

Updated Category News Views 20

Pioneering Technology in Leave Management AbsenceSoft is rolling out a tool that's about to shake up the HR world in a big way. MyAbsence, powered by AbsenceSoftAI, seems ready to cut down on the common confusions that send HR folks spinning around like they're in a two-step dance competition, juggling leave requests and compliance checks. It's all about getting the...

Continue Reading
WhiteFiber: Expanding North Carolina Data Center Capacity

Updated Category News Views 37

WhiteFiber's Strategic Leap in North Carolina When a company starts throwing millions around, you better perk your ears up. WhiteFiber's $60 million plunge into North Carolina's dirt has filled their cart with two hefty data center projects. They're not messing around—just look at that cash down, with NASDAQ:WYFI betting big on these Yadkin County sites. Smart move or...

Continue Reading
Hyundai Pushes Hydrogen Boundaries at 2026 Expo

Updated Category News Views 105

A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...

Continue Reading
Ian Marx Wins Pro Bono Honor at NJ Legal Awards

Updated Category News Views 81

A Champion in Legal Advocacy How often do we hear about a lawyer choosing the unglamorous path of pro bono work over the high-stakes allure of corporate law? Slam-dunk, you don’t. At the New Jersey Legal Awards, Ian S. Marx from Greenberg Traurig broke the mold, snagging the 'Pro Bono Lawyer of the Year' award. This isn’t just some pat on the back; it's recognition of...

Continue Reading
DRC's Grand Inga Project Sparks American Interest

Updated Category News Views 40

Transformative Power: Enter the Grand Inga The winds of change are gusting over the Congo River, with the United States and Democratic Republic of the Congo (DRC) soldiering forward on the Grand Inga hydropower complex. Friends, this isn't just another investment; it's an audacious move aimed at flipping the DRC's power dynamics upside down. Both nations are knee-deep in...

Continue Reading
Stellar Snacks Shakes Up Pretzel Sector with Bold Launch

Updated Category News Views 20

Stellar Snacks' audacious venture into olive oil-based pretzels Ever thought pretzels would stir up a storm? Well, Stellar Snacks sure did. They're celebrating a blockbuster year by rolling out a brand-new line of olive oil-baked pretzel braids across Sprouts Farmers Market nationwide. This isn't just any rollout. It's a carefully crafted endeavor tailored to redefine how...

Continue Reading

Top 5 Most Recently Viewed Articles

Lennox to Report Financial Results and 2026 Outlook Soon

Updated Category News Views 148

Lennox Financial Results and Future Guidance Announcement DALLAS - Lennox (NYSE: LII), recognized for its energy-efficient climate control solutions, is set to announce its fourth-quarter and full-year financial results for 2025 shortly before the market opens. This key announcement will occur on Wednesday, January 28, 2026. Alongside these results, the company will also...

Continue Reading
New S&P Lincoln Indices: A Bold Move in Private Loans

Updated Category News Views 263

The Shift in Private Loan Markets This takes me back to when the dot-com bubble burst—remember the chaos? Anyway, S&P Dow Jones Indices, that big player in the index game, is making waves again with the launch of the S&P Lincoln Senior Debt Indices. It’s a partnership with Lincoln International, and it’s all about filling a desperate gap in the private loan sector....

Continue Reading
UP Oncolytics Secures Grant to Advance Brain Cancer Therapy

Updated Category News Views 155

UP Oncolytics Earns Innovation Voucher for Cancer Drug Development UP Oncolytics, a forward-thinking biotech company located within the Helix 51 biomedical incubator, is making significant strides in the battle against aggressive forms of brain cancer. Recently, they were awarded an Illinois Innovation Voucher grant for $75,000, which will propel their collaboration with...

Continue Reading
Analyzing Market Sentiment Towards Philip Morris International

Updated Category News Views 180

Philip Morris International Inc: Market Sentiment Overview Philip Morris International Inc (NYSE: PM) has seen a notable increase in its short interest as a percentage of float, which has risen by 8.33% since the last report. Currently, the number of shares sold short stands at approximately 12.08 million, equating to 0.78% of the total shares that are available for...

Continue Reading
Silvaco Welcomes New CEO: A New Era of Innovation Ahead

Updated Category News Views 290

Silvaco's CEO Transition: What's Next? In a decisive move that signals a new chapter for Silvaco Group, Inc. (NASDAQ: SVCO), the company has announced the transition of its Chief Executive Officer. Dr. Babak Taheri, who has admirably led the business for nearly seven years, has stepped down, with Walden "Wally" C. Rhines, Ph.D., taking the helm as the new CEO. Leadership...

Continue Reading